Execution Capabilities are Second to None
Members of Origin’s board and management team have been involved in some of the fastest growing companies in their respective industries.
Chief Executive Officer, Director
Alexander Somjen has extensive experience serving as an officer and director of publicly listed and privately held companies across a broad range of sectors including technology, healthcare and cannabis. Most recently, Alexander served as President of a publicly traded, California based multi-state cannabis company and CEO of a publicly traded global investment company. Prior to that, Alexander spent over a decade in capital markets at a large financial institution working in both investment banking and sales and trading related capacities. Alexander holds an MBA from IE Business School.
Chief Financial Officer
Mr. Lee has over 15 years of extensive financial management experience with publicly traded companies. He is formerly CFO of Freeman Gold Corp. and prior, had progressively senior roles from Corporate Controller, VP Finance and Administration to Chief Financial Officer, for a TSXV listed gold producer with $400 million in revenue over nine years. His responsibilities included development and execution of financial strategy and operations, including regulatory reporting, financial planning and analysis, treasury, tax and audit. He also held prior Controller positions in the mining industry with various publicly traded companies including Prodigy Gold Inc. that was acquired for $340 million. Kelvin is currently CFO and Director of MegaWatt Lithium and Battery Metals Corp.; and CFO and Director of Karam Minerals Inc.; and CFO of Mantaro Silver Corp. Mr. Lee is a CPA, CGA (British Columbia).
Alfred Wong is a venture capitalist and entrepreneur with experience in a wide range of sectors including technology, cannabis, and consumer goods. Alfred is currently the Managing Director at Alfred & Company Advisors Inc, a boutique management consulting firm. Alfred was previously President & CEO of a public technology company listed on the Canadian Securities Exchange, and was a former President and Director of Growmax Capital.
In 2017, Alfred co-founded Nash Pharmaceuticals, an innovative drug-repurposing company, focusing in the developing drugs in the areas of non-alcoholic steatohepatitis, chronic kidney, and inflammatory bowel diseases. Nash was acquired by Algernon Pharmaceuticals in 2018 after successful pre-clinical and phase 1 trials.
Between 2016-2019, Alfred was President at Bullrun Capital where he conducted M&A due diligence, fundraising, and RTO transactions for private and public companies. Between 2011 and 2016, Alfred was an entrepreneur executive for several startups in Asia in the areas of financial technology and logistics.
Prior to his entrepreneurship ventures, Alfred supported the transportation & logistics equity research team at Credit Lyonnais Securities Asia in Hong Kong.
Board of Directors
Ms. Davies is a corporate securities lawyer with over 14 years experience working as legal counsel, corporate secretary and chief compliance officer to various privately held and publicly traded companies, primarily focused in the resource and technology sectors. Brianna has a broad range of international experience having held roles with companies with assets in North America, South America, Russia, Australia, Mali, Ethiopia and Burkina Faso. Brianna obtained a Juris Doctorate from the University of Toronto, Faculty of Law in 2005 and graduated Summa Cum Laude with an Honours B.A in Economics, from McMaster University in Hamilton, Canada in 2002. Brianna is a native English speaker with French language proficiency.
Michael Galego is an executive, lawyer and corporate director with extensive M&A, corporate finance and governance experience. Mr. Galego is currently CEO of Apollo Capital Advisory Corp. and sits on the board of directors of several public and private companies. Mr. Galego has been the co-founder of several businesses, including ICC Labs, Terrace Global and several other TSXV listed companies.
Jonathan S. Goldman
Jonathan is an accomplished real estate and infrastructure developer as well as business builder with over 25 years of work experience. Jonathan started his career in commercial real estate and subsequently founded, built, and sold one of the country’s most successful renewable energy development firms. He then joined Stafford Developments and became the president and co-owner in 2015. Stafford is a diversified private property development company that carries out land development, construction, and property management with its sister company Goldman Group. Stafford and Goldman have deployed over $1Bn of equity capital with current managed assets over $2Bn on behalf of investors. As a result, Jonathan brings a wealth of experience funding and executing the physical build out of many technically advanced facilities. Jonathan has recently been involved in founding multiple new businesses including a cannabis venture fund, a technology infrastructure business, a publicly traded international cannabis production company, a Canadian retail platform and a hospitality company. Outside of work, Jonathan is a member in good standing of the Young Presidents Organization (YPO), serves on the board of several charities and has recently made contributions to Mount Sinai Hospital, Baycrest, Sunnybrook Hospital, Lifeline, Crohn’s & Colitis Canada, Sick Kids Hospital, Boost Child and Youth Advocacy Centre and the United way to name a few.
Kyle Gould, CFA
Kyle Gould is a Co-Founder of Hyperion Capital Inc., a boutique advisory firm specializing in the Healthcare and Technology Sectors. Prior to Hyperion, Kyle served as a Director within GMP Securities L.P.’s cannabis practice where he aided in raising and advising over $10 billion worth of corporate mandates across 100+ transactions. During his time at GMP, the firm was ranked #2 globally for cannabis activity. Kyle held roles for GMP in both New York City and Toronto. He started his career at BMO Capital Markets Corp. in New York where he focused on leveraged finance for North American based companies.
Kyle is a CFA Charterholder and graduated from Dalhousie University with a major in Finance
Jaiveer Singh is the CEO at Mint Pharmaceuticals. Under his leadership, Mint has emerged as one of the country’s most reputable and leading generic pharmaceutical companies over the past decade. Jaiveer is also an active early stage Investor passionate about supporting fellow entrepreneurs in building differentiated and high-quality businesses and currently serves on several boards. He was the Chairman of Truverra until acquired by The Supreme Cannabis Company in 2019 and is a Co-founder of Los Angeles based hedge fund Medina Singh Partners.
Talk to Our Team
Want to make psychedelic therapy part of your investing strategy? Connect with our team to find out more.